X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11010) 11010
Book Chapter (56) 56
Magazine Article (49) 49
Newsletter (18) 18
Reference (5) 5
Dissertation (3) 3
Web Resource (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Publication (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9618) 9618
angiotensin-converting enzyme inhibitors - therapeutic use (5560) 5560
male (5113) 5113
female (4782) 4782
angiotensin-converting enzyme inhibitors - adverse effects (4087) 4087
middle aged (3668) 3668
aged (3456) 3456
hypertension - drug therapy (3008) 3008
hypertension (2353) 2353
adult (2096) 2096
cardiac & cardiovascular systems (1785) 1785
treatment outcome (1621) 1621
antihypertensive agents - therapeutic use (1598) 1598
risk factors (1582) 1582
pharmacology & pharmacy (1507) 1507
animals (1495) 1495
angiotensin (1486) 1486
blood pressure - drug effects (1413) 1413
drug therapy, combination (1388) 1388
angiotensin-converting enzyme inhibitors - administration & dosage (1357) 1357
heart failure - drug therapy (1356) 1356
mortality (1352) 1352
ace inhibitors (1276) 1276
angiotensin-converting enzyme inhibitors (1257) 1257
angiotensin-converting enzyme inhibitors - pharmacology (1218) 1218
heart failure (1216) 1216
medicine, general & internal (1208) 1208
adrenergic beta-antagonists - therapeutic use (1070) 1070
renin-angiotensin system - drug effects (1065) 1065
antihypertensive agents - adverse effects (1057) 1057
peripheral vascular disease (999) 999
enzymes (974) 974
aged, 80 and over (973) 973
drug therapy (964) 964
blood-pressure (933) 933
angiotensin-converting enzyme (929) 929
double-blind method (885) 885
enalapril (854) 854
hypertension - physiopathology (837) 837
captopril (803) 803
blood pressure (791) 791
calcium channel blockers - therapeutic use (777) 777
angiotensin ii type 1 receptor blockers - therapeutic use (771) 771
medicine & public health (769) 769
urology & nephrology (747) 747
time factors (725) 725
retrospective studies (724) 724
therapy (696) 696
care and treatment (683) 683
diuretics - therapeutic use (679) 679
angiotensin receptor antagonists - therapeutic use (674) 674
hypertension - complications (660) 660
risk (654) 654
prospective studies (649) 649
research (613) 613
diabetes (611) 611
renin-angiotensin system (599) 599
randomized controlled trials as topic (595) 595
enalapril - adverse effects (591) 591
follow-up studies (588) 588
diuretics (584) 584
cardiology (579) 579
angiotensin receptor antagonists (568) 568
rats (567) 567
angioedema - chemically induced (565) 565
enzyme inhibitors (563) 563
health aspects (562) 562
heart-failure (552) 552
internal medicine (552) 552
myocardial-infarction (548) 548
enalapril - therapeutic use (546) 546
abridged index medicus (536) 536
heart failure - physiopathology (534) 534
clinical trials as topic (530) 530
analysis (528) 528
dose-response relationship, drug (528) 528
cardiovascular disease (502) 502
prevention (488) 488
double-blind (481) 481
disease (476) 476
converting enzyme-inhibitors (471) 471
antihypertensive agents - administration & dosage (468) 468
management (452) 452
prognosis (452) 452
adolescent (449) 449
cardiovascular (448) 448
angiotensin converting enzyme (445) 445
angiotensin-converting enzyme inhibitor (421) 421
cardiovascular diseases (421) 421
left-ventricular dysfunction (413) 413
captopril - adverse effects (411) 411
heart attacks (409) 409
captopril - therapeutic use (402) 402
myocardial infarction - drug therapy (385) 385
calcium channel blockers - adverse effects (384) 384
patients (383) 383
peptidyl-dipeptidase a (382) 382
angiotensin ii type 1 receptor blockers - adverse effects (381) 381
renin-angiotensin system - physiology (373) 373
chronic disease (370) 370
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10329) 10329
German (303) 303
French (160) 160
Japanese (117) 117
Spanish (85) 85
Russian (68) 68
Italian (51) 51
Danish (32) 32
Polish (26) 26
Swedish (24) 24
Norwegian (23) 23
Portuguese (22) 22
Chinese (21) 21
Dutch (20) 20
Hungarian (18) 18
Czech (15) 15
Serbian (7) 7
Finnish (6) 6
Hebrew (6) 6
Slovak (5) 5
Croatian (4) 4
Romanian (4) 4
Turkish (3) 3
Lithuanian (2) 2
Bulgarian (1) 1
Korean (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | WARFARIN | REGIMENS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
Cochrane library, ISSN 1465-1858, 2014, Volume 2014, Issue 8, p. CD009096
.... Objectives To compare the effects of ACE inhibitors and ARBs on total mortality and cardiovascular events, and their rates of withdrawals due to adverse effects (WDAEs... 
Hypertension | Kidney disease | Treatment: pharmacological | Stroke | Angiotensin Receptor Antagonists | Angiostensin‐converting enzyme (ACE) inhibitors | Pharmacological Therapies | Hypotension | Angiotensin‐Converting Enzyme Inhibitors | Randomized Controlled Trials as Topic | Heart Diseases | Antihypertensive Agents | Heart & circulation | Essential Hypertension | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | LONG-TERM | Antihypertensive Agents [adverse effects; therapeutic use] | LOSARTAN | Randomized Controlled Trials as Topic Stroke [mortality] | MYOCARDIAL-INFARCTION | Angiotensin-Converting Enzyme Inhibitors [adverse effects; therapeutic use] | HEART-FAILURE | RANDOMIZED CONTROLLED-TRIAL | COMBINATION | Heart Diseases [mortality] | MEDICINE, GENERAL & INTERNAL | HIGH-RISK PATIENTS | Hypertension [complications; drug therapy; mortality] | RAMIPRIL | P-WAVE DISPERSION | LEFT-VENTRICULAR MASS | Angiotensin Receptor Antagonists [adverse effects; therapeutic use] | Humans | Hypertension - drug therapy | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Heart Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Hypertension - complications | Hypertension - mortality | Stroke - mortality | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 11, pp. 993 - 1004
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9644, pp. 1174 - 1183
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 3, pp. 211 - 221
... kidney disease and hyperkalemia who were receiving renin–angiotensin–aldosterone system (RAAS) inhibitors. Hyperkalemia is associated with life-threatening cardiac arrhythmias and increased mortality... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | MILD PATIENTS HOSPITALIZATION | MANAGEMENT | THERAPY | GUIDELINES | SODIUM POLYSTYRENE SULFONATE | INTESTINAL NECROSIS | RESONIUM | EPLERENONE | WORSENING RENAL-FUNCTION | Single-Blind Method | Prospective Studies | Hyperkalemia - drug therapy | Humans | Middle Aged | Male | Secondary Prevention | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - drug therapy | Polymers - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Polymers - adverse effects | Hyperkalemia - etiology | Mineralocorticoid Receptor Antagonists - adverse effects | Mineralocorticoid Receptor Antagonists - therapeutic use | Disease-Free Survival | Potassium - blood | Renin-Angiotensin System - drug effects | Aged | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Renin inhibitors | Hyperkalemia | Care and treatment | Dosage and administration | Kidney diseases | Risk factors | Inhibitor drugs | Kidneys | Risk groups | Medical treatment | Mortality | Aldosterone | Patients | Renin | Angiotensin | Hypokalemia | Potassium | Constipation | Index Medicus | Abridged Index Medicus
Journal Article
Marine drugs, ISSN 1660-3397, 2010, Volume 8, Issue 4, pp. 1080 - 1093
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
.... We investigated the renal effects of ramipril (an ACE inhibitor), telmisartan (an ARB), and their combination in patients aged 55 years or older with established atherosclerotic vascular disease or with diabetes with end-organ damage... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article